SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Elizabeth Arden, Inc. (RDEN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RDEN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.43
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.46
Book Value / Share$0.00
Revenue / Share$32.35
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2007 |
$1.30 |
$1.13B |
$37.33M |
3.3% |
| 2008 |
$0.68 |
$1.14B |
$19.9M |
1.7% |
| 2009 |
$-0.22 |
$1.07B |
$-6.16M |
-0.6% |
| 2010 |
$0.68 |
$1.1B |
$19.53M |
1.8% |
| 2011 |
$1.41 |
$1.18B |
$40.99M |
3.5% |
| 2012 |
$1.91 |
$1.24B |
$57.42M |
4.6% |
| 2013 |
$1.33 |
$1.34B |
$40.71M |
3% |
| 2014 |
$-4.95 |
$1.16B |
$-147.2M |
-12.6% |
| 2015 |
$-7.56 |
$971.1M |
$-225.29M |
-23.2% |
| 2016 |
$-2.46 |
$966.73M |
$-73.51M |
-7.6% |
